Congruent with the neuroprotective roles of STING signaling in MS, microparticle-encapsulated cGAMP could mediate neuroprotection in EAE in a STING-dependent manner, specifically decreasing disease score and reduced relapses (123). The gene discussed is STING1; the disease is myeloid sarcoma.